UnitedHealth Group Incorporated is an American multinational for-profit company specializing in health insurance and health care services based in Eden Prairie, Minnesota. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's seventh-largest company by revenue and the largest health care company by revenue. The company is ranked eighth on the 2024 Fortune Global 500.
trading_symbol | registrant_name | time | price | change | percentage_change |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 2025-10-16 22:23:33 | 354.3 | -2.37 | -0.66 |
trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNH | 0000731766 | UNITEDHEALTH GROUP INC | US91324P1021 | 549300GHBMY8T5GXDE41 | 411321939 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 1 HEALTH DRIVE | EDEN PRAIRIE | MN | 55344 | UNITED STATES | US | 1-800-328-5979 | 1 HEALTH DRIVE, EDEN PRAIRIE, MN, 55344 | 1 HEALTH DRIVE, EDEN PRAIRIE, MN, 55344 | UNITED HEALTHCARE CORP | Managed healthcare | 1974 | Stephen J. Hemsley | 380,000 | https://unitedhealthgroup.com/ | 468,433,146,650 | 905,000,000 | 905,673,625 | UnitedHealth Group Incorporated is an American multinational for-profit company specializing in health insurance and health care services based in Eden Prairie, Minnesota. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's seventh-largest company by revenue and the largest health care company by revenue. The company is ranked eighth on the 2024 Fortune Global 500. | 2025-10-10 19:01:03 |
Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
---|---|---|---|---|---|---|
2024 | 468,433,146,650 | 23,805,388,424 | 5.354 | 914,712,333 | -7,221,776 | -0.7833 |
2023 | 444,627,758,226 | -34,923,122,019 | -7.2825 | 921,934,109 | -10,912,493 | -1.1698 |
2022 | 479,550,880,245 | 103,388,095,185 | 27.4849 | 932,846,602 | -8,052,544 | -0.8558 |
Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
---|---|---|---|---|---|---|---|---|
Heather Cianfrocco | CEO, Executive Vice President | 2024 | 1,000,000 | 0 | 6,001,359 | 1,500,000 | 948,035 | 11,449,467 |
Christopher Zaetta | Chief Legal Officer, Executive Vice President, Corporate Secretary | 2024 | 748,077 | 0 | 3,750,990 | 890,000 | 234,152 | 6,873,295 |
Andrew Witty | Chief Executive Officer | 2024 | 1,500,000 | 0 | 17,250,065 | 1,500,000 | 339,097 | 26,339,215 |
John Rex | President, CFO | 2024 | 1,342,308 | 0 | 11,250,762 | 2,100,000 | 287,929 | 18,731,183 |
Erin Mcsweeney | Chief People Officer, Executive Vice President | 2024 | 800,000 | 0 | 3,375,580 | 825,000 | 142,835 | 6,268,428 |
Fiscal Year | Employee Count |
---|---|
2024 | 400,000 |
2022 | 400,000 |
2021 | 350,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 400,278,000,000 | 371,622,000,000 | 324,162,000,000 |
Cost Of Revenue | 46,694,000,000 | 38,770,000,000 | 33,703,000,000 |
Gross Profit | — | — | — |
Research And Development Expenses | — | — | — |
General And Administrative Expenses | 53,013,000,000 | 54,628,000,000 | 47,782,000,000 |
Operating Expenses | 367,991,000,000 | 339,264,000,000 | 295,727,000,000 |
Operating Income | 32,287,000,000 | 32,358,000,000 | 28,435,000,000 |
Net Income | 14,405,000,000 | 22,381,000,000 | 20,120,000,000 |
Earnings Per Share Basic | 15.64 | 24.12 | 21.47 |
Earnings Per Share Diluted | 15.51 | 23.86 | 21.18 |
Weighted Average Shares Outstanding Basic | 921,000,000 | 928,000,000 | 937,000,000 |
Weighted Average Shares Outstanding Diluted | 929,000,000 | 938,000,000 | 950,000,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Cash And Cash Equivalents | 25,312,000,000 | 25,427,000,000 | 23,365,000,000 |
Marketable Securities Current | 320,000,000 | 313,000,000 | 374,000,000 |
Accounts Receivable | 22,365,000,000 | 21,276,000,000 | 17,681,000,000 |
Inventories | 3,800,000,000 | 2,800,000,000 | 3,500,000,000 |
Non Trade Receivables | 6,062,000,000 | 5,693,000,000 | — |
Other Assets Current | 411,000,000 | 570,000,000 | 753,000,000 |
Total Assets Current | 85,779,000,000 | 78,437,000,000 | 69,069,000,000 |
Marketable Securities Non Current | 161,000,000 | 246,000,000 | 265,000,000 |
Property Plant And Equipment | 10,553,000,000 | 11,450,000,000 | 10,128,000,000 |
Other Assets Non Current | 19,590,000,000 | 17,298,000,000 | 15,027,000,000 |
Total Assets Non Current | 212,499,000,000 | 195,283,000,000 | 176,636,000,000 |
Total Assets | 298,278,000,000 | 273,720,000,000 | 245,705,000,000 |
Accounts Payable | 34,337,000,000 | 31,958,000,000 | 27,715,000,000 |
Deferred Revenue | 3,317,000,000 | 3,355,000,000 | 3,075,000,000 |
Short Term Debt | 4,545,000,000 | 4,274,000,000 | 3,110,000,000 |
Other Liabilities Current | 27,346,000,000 | 27,072,000,000 | 26,281,000,000 |
Total Liabilities Current | 103,769,000,000 | 99,054,000,000 | 89,237,000,000 |
Long Term Debt | 72,359,000,000 | 58,263,000,000 | 54,513,000,000 |
Other Liabilities Non Current | 15,939,000,000 | 14,463,000,000 | 12,839,000,000 |
Total Liabilities Non Current | 91,918,000,000 | 75,747,000,000 | 70,121,000,000 |
Total Liabilities | 195,687,000,000 | 174,801,000,000 | 159,358,000,000 |
Common Stock | 9,000,000 | 9,000,000 | 9,000,000 |
Retained Earnings | 96,036,000,000 | 95,774,000,000 | 86,156,000,000 |
Accumulated Other Comprehensive Income | -3,387,000,000 | -7,027,000,000 | -8,393,000,000 |
Total Shareholders Equity | 98,268,000,000 | 94,421,000,000 | 81,450,000,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Depreciation And Amortization | 4,099,000,000 | 3,972,000,000 | 3,400,000,000 |
Share Based Compensation Expense | 1,018,000,000 | 1,059,000,000 | 925,000,000 |
Other Non Cash Income Expense | 28,000,000 | 505,000,000 | 331,000,000 |
Change In Accounts Receivable | 1,437,000,000 | 3,114,000,000 | 2,523,000,000 |
Change In Inventories | — | — | — |
Change In Non Trade Receivables | — | — | — |
Change In Other Assets | 4,140,000,000 | 2,444,000,000 | 1,374,000,000 |
Change In Accounts Payable | 2,463,000,000 | 3,516,000,000 | 1,964,000,000 |
Change In Other Liabilities | — | — | — |
Cash From Operating Activities | 24,204,000,000 | 29,068,000,000 | 26,206,000,000 |
Purchases Of Marketable Securities | 27,308,000,000 | 18,314,000,000 | 18,825,000,000 |
Sales Of Marketable Securities | 18,514,000,000 | 7,307,000,000 | 5,907,000,000 |
Acquisition Of Property Plant And Equipment | 3,499,000,000 | 3,386,000,000 | 2,802,000,000 |
Acquisition Of Business | 13,408,000,000 | 10,136,000,000 | 21,458,000,000 |
Other Investing Activities | 1,667,000,000 | 960,000,000 | 793,000,000 |
Cash From Investing Activities | -20,527,000,000 | -15,574,000,000 | -28,476,000,000 |
Tax Withholding For Share Based Compensation | — | — | — |
Payments Of Dividends | 7,533,000,000 | 6,761,000,000 | 5,991,000,000 |
Issuance Of Common Stock | 1,846,000,000 | 1,353,000,000 | 1,253,000,000 |
Repurchase Of Common Stock | 9,000,000,000 | 8,000,000,000 | 7,000,000,000 |
Issuance Of Long Term Debt | 17,811,000,000 | 6,394,000,000 | 14,819,000,000 |
Repayment Of Long Term Debt | 3,000,000,000 | 2,125,000,000 | 3,015,000,000 |
Other Financing Activities | -1,645,000,000 | -1,150,000,000 | -1,944,000,000 |
Cash From Financing Activities | -3,512,000,000 | -11,529,000,000 | 4,226,000,000 |
Change In Cash | -115,000,000 | 2,062,000,000 | 1,990,000,000 |
Cash At End Of Period | 25,312,000,000 | 25,427,000,000 | 23,365,000,000 |
Income Taxes Paid | 4,620,000,000 | 6,078,000,000 | 5,222,000,000 |
Interest Paid | 3,594,000,000 | 3,035,000,000 | 1,945,000,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Earnings Per Share | 15.64 | 24.12 | 21.47 |
Price To Earnings Ratio | 32.344 | 21.8271 | 24.694 |
Earnings Growth Rate | -35.1575 | 12.3428 | 17.1304 |
Price Earnings To Growth Ratio | -0.92 | 1.7684 | 1.4415 |
Book Value Per Share | 111.3909 | 106.5938 | 92.1526 |
Price To Book Ratio | 4.5413 | 4.939 | 5.7533 |
Ebitda | 27,030,000,000 | 35,677,000,000 | 30,834,000,000 |
Enterprise Value | 517,489,060,000 | 525,674,160,000 | 531,036,660,000 |
Dividend Yield | 0.0162 | 0.0138 | 0.0121 |
Dividend Payout Ratio | 0.5229 | 0.3021 | 0.2978 |
Debt To Equity Ratio | 0.7826 | 0.6623 | 0.7075 |
Capital Expenditures | 3,202,000,000 | 5,294,000,000 | 4,559,000,000 |
Free Cash Flow | 21,002,000,000 | 23,774,000,000 | 21,647,000,000 |
Return On Equity | 0.1466 | 0.237 | 0.247 |
One Year Beta | 0.1284 | 0.2797 | 0.5775 |
Three Year Beta | 0.4389 | 0.5348 | 0.9287 |
Five Year Beta | 0.8192 | 0.8616 | 0.9205 |
Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
---|---|---|---|---|---|
Noseworthy John H | Director | 2025-10-01 | 261 | A | 6,693 |
HOOPER MICHELE J | Director | 2025-10-01 | 162 | A | 40,877 |
Baker Charles D. | Director | 2025-10-01 | 260 | A | 1,516 |
MONTGOMERY RICE VALERIE MD | Director | 2025-10-01 | 270 | A | 6,897 |
Gil Kristen | Director | 2025-10-01 | 162 | A | 1,900 |
Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Sheldon Whitehouse | Senator | 2025-10-03 | Sale (Full) | 2025-09-04 | Self | $15,001 - $50,000 |
Markwayne Mullin | Senator | 2025-10-01 | Purchase | 2025-09-24 | Joint | $15,001 - $50,000 |
Sheldon Whitehouse | Senator | 2025-09-03 | Sale (Full) | 2025-08-28 | Spouse | $15,001 - $50,000 |
Angus S King, Jr. | Senator | 2025-08-18 | Sale (Full) | 2025-07-15 | Spouse | $1,001 - $15,000 |
Markwayne Mullin | Senator | 2025-08-18 | Sale (Partial) | 2025-08-01 | Joint | $15,001 - $50,000 |
Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Valerie Hoyle | 2025-10-10 | OR04 | Sale | 2025-09-23 | Spouse | $1,001 - $15,000 |
Gilbert Cisneros | 2025-10-10 | CA31 | Purchase | 2025-09-05 | — | $1,001 - $15,000 |
Richard Dean Dr McCormick | 2025-10-09 | GA06 | Sale (Partial) | 2025-09-18 | — | $1,001 - $15,000 |
Richard Dean Dr McCormick | 2025-09-17 | GA06 | Purchase | 2023-03-15 | — | $1,001 - $15,000 |
Valerie Hoyle | 2025-09-12 | OR04 | Purchase | 2024-10-29 | Spouse | $1,001 - $15,000 |
Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
---|---|---|---|---|
Bill Few Associates, Inc. | 2025-09-30 | 266,109 | 771 | 345.1479 |
WILLNER & HELLER, LLC | 2025-09-30 | 705,050 | 2,042 | 345.2742 |
Carnegie Investment Counsel | 2025-09-30 | 36,471,081 | 105,621 | 345.3014 |
AMI INVESTMENT MANAGEMENT INC | 2025-09-30 | 3,334,908 | 9,658 | 345.3001 |
LINCOLN CAPITAL CORP | 2025-09-30 | 1,272,421 | 3,685 | 345.2974 |
Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
---|---|---|---|---|---|---|
NORTH COUNTRY FUNDS | 2025-08-31 | The North Country Large Cap Equity Fund | NCEGX | 3,200 | 991,584 | 0.7768 |
ALLSPRING FUNDS TRUST | 2025-07-31 | Class A | STAFX | 17,981 | 4,487,338.36 | 0.4367 |
ALLSPRING FUNDS TRUST | 2025-07-31 | Institutional Class | EVSIX | 15,584 | 3,889,143.04 | 0.298 |
ALLSPRING FUNDS TRUST | 2025-07-31 | Administrator Class | EVSYX | 15,584 | 3,889,143.04 | 0.298 |
ALLSPRING FUNDS TRUST | 2025-07-31 | Class C | EVSTX | 15,584 | 3,889,143.04 | 0.298 |